semaglutide vs mounjaro side effects Wegovy Wegovy vs. Mounjaro: Difference Between

In summary, therapeutic management of secondary DM in acromegalic patients should be based on a combination of metformin and GLP1-RA, as a first therapeutic approach, in line with the latest scientific evidence, in order to take advantage of the cardioprotective effects of GLP1-RA

GLP-1 Agonists (Semaglutide/Liraglutide) Pathway: Cagrilintide is an amylin analog

Direct head-to-head comparisons are not possible because the trials differed in duration, population and study design, but reporting outcomes side-by-side provides context

The separation was performed using a gradient elution with water mixed with acetonitrile

Competing interests None of the authors have competing interest